BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18324968)

  • 21. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
    Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
    Cozzolino I; Varone V; Picardi M; Baldi C; Memoli D; Ciancia G; Selleri C; De Rosa G; Vetrani A; Zeppa P
    Cancer Cytopathol; 2016 Feb; 124(2):135-43. PubMed ID: 26414904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
    Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
    Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse large B-cell lymphoma of the orbit: clinicopathologic, immunohistochemical, and prognostic features of 20 cases.
    Stacy RC; Jakobiec FA; Herwig MC; Schoenfield L; Singh A; Grossniklaus HE
    Am J Ophthalmol; 2012 Jul; 154(1):87-98.e1. PubMed ID: 22503694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.
    Lossos IS; Alizadeh AA; Rajapaksa R; Tibshirani R; Levy R
    Blood; 2003 Jan; 101(2):433-40. PubMed ID: 12509382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.
    Löfström B; Backlin C; Pettersson T; Lundberg IE; Baecklund E
    J Rheumatol; 2011 Sep; 38(9):1891-7. PubMed ID: 21724695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms.
    Natkunam Y; Vainer G; Chen J; Zhao S; Marinelli RJ; Hammer AS; Hamilton-Dutoit S; Pikarsky E; Amir G; Levy R; Yisraeli JK; Lossos IS
    Haematologica; 2007 Feb; 92(2):176-83. PubMed ID: 17296566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL.
    van Galen JC; Muris JJ; Oudejans JJ; Vos W; Giroth CP; Ossenkoppele GJ; Otte AP; Raaphorst FM; Meijer CJ
    J Clin Pathol; 2007 Feb; 60(2):167-72. PubMed ID: 16837630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
    Paik JH; Jeon YK; Park SS; Kim YA; Kim JE; Huh J; Lee SS; Kim WH; Kim CW
    Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the stomach and small intestine.
    Kwon MS; Go JH; Choi JS; Lee SS; Ko YH; Rhee JC; Ree HJ
    Am J Surg Pathol; 2003 Jun; 27(6):790-8. PubMed ID: 12766583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.
    Amen F; Horncastle D; Elderfield K; Banham AH; Bower M; Macdonald D; Kanfer E; Naresh KN
    Histopathology; 2007 Jul; 51(1):70-9. PubMed ID: 17593082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Study of the Newer Prognostic Markers in Diffuse Large B Cell Lymphomas.
    Sahai K; Gangadharan V; Singh HP; Mani NS
    Med J Armed Forces India; 2011 Jan; 67(1):41-5. PubMed ID: 27365760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.
    Baecklund E; Sundström C; Ekbom A; Catrina AI; Biberfeld P; Feltelius N; Klareskog L
    Arthritis Rheum; 2003 Jun; 48(6):1543-50. PubMed ID: 12794821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas.
    Loo SK; Ch'ng ES; Lawrie CH; Muruzabal MA; Gaafar A; Pomposo MP; Husin A; Md Salleh MS; Banham AH; Pedersen LM; Møller MB; Green TM; Wong KK
    Pathology; 2017 Dec; 49(7):731-739. PubMed ID: 29074044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B-cell lymphomas.
    Rayman N; Lam KH; van der Holt B; Koss C; van Leeuwen J; Budel LM; Mulder AH; Sonneveld P; Delwel R
    Eur J Haematol; 2011 Jun; 86(6):466-76. PubMed ID: 21457344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes.
    Watanuki-Miyauchi R; Kojima Y; Tsurumi H; Hara T; Goto N; Kasahara S; Saio M; Moriwaki H; Takami T
    Pathol Int; 2005 Jun; 55(6):324-30. PubMed ID: 15943789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic evaluation of nodal diffuse large B cell lymphoma by immunohistochemical profiles with emphasis on CD138 expression as a poor prognostic factor.
    Oh YH; Park CK
    J Korean Med Sci; 2006 Jun; 21(3):397-405. PubMed ID: 16778379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in germinal centre and non-germinal center phenotype in gastric and intestinal diffuse large B-cell lymphomas.
    Mitchell KA; Finn WG; Owens SR
    Leuk Lymphoma; 2008 Sep; 49(9):1717-23. PubMed ID: 18798105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma.
    Gualco G; Bacchi LM; Domeny-Duarte P; Natkunam Y; Bacchi CE
    Mod Pathol; 2012 Nov; 25(11):1439-45. PubMed ID: 22743653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
    Bodoor K; Matalka I; Hayajneh R; Haddad Y; Gharaibeh W
    Asian Pac J Cancer Prev; 2012; 13(7):3037-46. PubMed ID: 22994707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.